|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 37/08 | (2006.01) |
| (11) | Number of the document | 3064511 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16161244.5 |
| Date of filing the European patent application | 2009-10-27 | |
| (97) | Date of publication of the European application | 2016-09-07 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-18 |
| (46) | Date of publication of the claims translation | 2018-07-10 |
| (30) | Number | Date | Country code |
| 260307 | 2008-10-29 | US |
| (72) |
PAPADOPOULOS, Nicholas J, US
FAIRHURST, Jeanette L, US
HUANG, Tammy T, US
MARTIN, Joel H, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Žmogaus antikūnų, pasižyminčių aukštu afiniškumu žmogaus IL-4 receptoriui, medicininis panaudojimas |
| MEDICAL USE OF HIGH AFFINITY HUMAN ANTIBODIES TO HUMAN IL-4 RECEPTOR |
| Payment date | Validity (years) | Amount | |
| 2025-09-23 | 17 | 347.00 EUR |
| 2026-10-27 |